AcoArt sICAS: DCB in the Treatment of Symptomatic Intracranial Atherosclerotic Stenosis

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 180 participants.

Also called NCT04631055

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 180 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04631055
Other papers using this trial's data
  • Comparison of drug-coated balloon with bare-metal stent in patients with symptomatic intracranial atherosclerotic stenosis: the AcoArt sICAS randomized clinical trial Journal of neurointerventional surgery, 2026-01-13 DOI, PubMed 40010849

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04631055. Randomized; single masking; primary purpose treatment. Start 2021-06-04 (actual); primary completion 2023-04-10 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
AcoArt sICAS: DCB in the Treatment of Symptomatic Intracranial Atherosclerotic Stenosis
Condition
Intracranial Atherosclerosis
Condition
Stroke
Intervention (Device)
drug coated balloon
Intervention (Device)
stent system
Lead sponsor
Acotec Scientific Co., Ltd (class: industry)
Collaborator
Beijing Tiantan Hospital (class: other)

Record details

Record id
cardio:ct-nct04631055
Content hash
036578a568a6b1230203b3c66b6bdb655ba57a2b29128b1a38e849cec41766af